Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WELLSTEIN, A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 60

  • Page / 3
Export

Selection :

  • and

KREATININBESTIMMUNG IN SERUM MIT HILFE EINER EINFACHEN KINETISCHEN METHODE AUF DEM EPPENDORF-ENZYMMESSPLATZ 5080. = DOSAGE DE LA CREATININE SERIQUE A L'AIDE D'UNE SIMPLE METHODE CINETIQUE EN UTILISANT L'APPAREIL DE MESURE EPPENDORF 5080SCHMIDT EW; WELLSTEIN A.1978; MED. LAB.; DTSCH.; DA. 1978; VOL. 31; NO 6; PP. 150-154; BIBL. 10 REF.Article

EINFLUSS DER HAEMOLYSE AUF DIE AKTIVITAETSBESTIMMUNG DES HERZMUSKELSPEZIFISCHEN CK-ISOENZYMES MB. = INFLUENCE DE L'HEMOLYSE SUR L'EVALUATION DE L'ACTIVITE DE L'ISOZYME MB DE LA CREATINE KINASE SPECIFIQUE DU MUSCLE CARDIAQUEWELLSTEIN A; SCHMIDT EW.1977; AERZTL. LAB.; DTSCH.; DA. 1977; VOL. 23; NO 8; PP. 334-336; ABS. ANGL.; BIBL. 6 REF.Article

BETA -ADRENOCEPTOR SITES IN MATURING RED BLOOD CELLS OF THE RAT: DIFFERING DEVELOPMENT OF AGONIST AND ANTAGONIST BINDINGWIEMER G; WELLSTEIN A; PALM D et al.1982; EUR. J. PHARMACOL.; ISSN 0014-2999; NLD; DA. 1982; VOL. 77; NO 2-3; PP. 167-170; BIBL. 10 REF.Article

CREATINKINASE-ISOENZYM MB UND DER QUOTIENT CK/GOT BEI DER DIFFERENTIALDIAGNOSE DES AKUTEN HERZINFARKTES. = ISOENZYME MB DE LA CREATINE KINASE ET QUOTIENT CK/GOT DANS LE DIAGNOSTIC DIFFERENTIEL DE L'INFARCTUS AIGU DU MYOCARDESCHMIDT EW; WELLSTEIN A; MOLL A et al.1977; MED. KLIN.; DTSCH.; DA. 1977; VOL. 72; NO 35; PP. 1368-1371; ABS. ANGL.; BIBL. 14 REF.Article

Growth factor targeted and conventional therapy of breast cancerWELLSTEIN, A.Breast cancer research and treatment. 1994, Vol 31, Num 2-3, pp 141-151, issn 0167-6806Article

Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptorsWELLSTEIN, A; PITSCHNER, H. F.Naunyn-Schmiedeberg's archives of pharmacology. 1988, Vol 338, Num 1, pp 19-27, issn 0028-1298Article

STUDY TO CONFIRM THE LECK OF SEVERE CARDIAC SIDE-EFFECTS FOLLOWING TREATMENT WITH THE BETA-ADRENERGIC DRUG FENOTEROLMEINEN K; BREINL H; SCHMIDT EW et al.1978; GYNECOL. OBSTETR. INVEST.; CHE; DA. 1978; VOL. 9; NO 6; PP. 319-324; BIBL. 15 REF.Article

NECROSE DU MYOCARDE PAR TOCOLYSE AVEC LE FENOTEROL.MEINEN K; BREINL H; SCHMIDT EW et al.1979; J. GYNECOL. OBSTETR. BIOL. REPROD.; FRA; DA. 1979; VOL. 8; NO 1; PP. 23-25; ABS. ENG; BIBL. 15 REF.Article

Dose-response curves of pirenzepine in man in relation to M1- and M2-cholinoceptor occupancyPITSCHNER, H. F; WELLSTEIN, A.Naunyn-Schmiedeberg's archives of pharmacology. 1988, Vol 338, Num 2, pp 207-210, issn 0028-1298Article

ZUR FRAGE DER MYOCARDSCHAEDIGUNG DURCH FENOTEROL. (KLINISCH-CHEMISCHE UNTERSUCHUNGEN UNTER BESONDERER BERUECKSICHTIGUNG DES HERZMUSKELSPEZIFISCHEN CREATINKINASE-ISOENZYMS MB). = SUR LA QUESTION DE LA LESION DU MYOCARDE PAR LE FENOTEROL. (ETUDES CLINICO-CHIMIQUES EN TENANT COMPTE EN PARTICULIER DE L'ISOENZYME SPECIFIQUE MYOCARDIQUE DE LA CREATINE-KINASE MB)WELLSTEIN A; BREINL H; MEINEN K et al.1977; Z. GEBURTSH. PERINATOL.; DTSCH.; DA. 1977; VOL. 181; NO 6; PP. 402-406; ABS. ANGL.; BIBL. 15 REF.Article

Penbutolol: β-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in manWELLSTEIN, A; PALM, D.European journal of clinical pharmacology. 1985, Vol 29, Num 3, pp 293-300, issn 0031-6970Article

Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1MASHOUR, G. A; WANG, H.-L; CABAL-MANZANO, R et al.Journal of investigative dermatology. 1999, Vol 113, Num 3, pp 398-402, issn 0022-202XConference Paper

The potential role of the heparin-binding growth factor pleiotrophin in breast cancerRIEGEL, A. T; WELLSTEIN, A.Breast cancer research and treatment. 1994, Vol 31, Num 2-3, pp 309-314, issn 0167-6806Article

d-Sotalol reduces heart rate in vivo through a β-adrenergic receptor-independent mechanismYASUDA, S. U; BARBEY, J. T; FUNCK-BRENTANO, C et al.Clinical pharmacology and therapeutics. 1993, Vol 53, Num 4, pp 436-442, issn 0009-9236Article

Structure of the human heparin-binding growth factor gene pleiotrophinLAI, S; CZUBAYKO, F; TATE RIEGEL, A et al.Biochemical and biophysical research communications (Print). 1992, Vol 187, Num 2, pp 1113-1122, issn 0006-291XArticle

Purification of PO-B, a protein that has increased affinity for the pro-opiomelanocortin gene promoter after dephosphorylationWELLSTEIN, A; DOBRENSKI, A. F; RADONOVICH, M. N et al.The Journal of biological chemistry (Print). 1991, Vol 266, Num 19, pp 12234-12241, issn 0021-9258Article

Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazaprilBELZ, G. G; ESSIG, J; WELLSTEIN, A et al.Journal of cardiovascular pharmacology. 1987, Vol 9, Num 2, pp 219-224, issn 0160-2446Article

Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteersWELLSTEIN, A; ESSIG, J; BELZ, G. G et al.Clinical pharmacology and therapeutics. 1987, Vol 41, Num 6, pp 639-644, issn 0009-9236Article

Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animalsZUGMAIER, G; LIPPMAN, M. E; WELLSTEIN, A et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 22, pp 1716-1724, issn 0027-8874Article

KLINIK UND LABORBEFUNDE BEI MALIGNER HYPERTHERMIE IM KINDESALTER UNTER BESONDERER BERUECKSICHTIGUNG DER CREATINKINASE-ISOENZYME. = CLINIQUE ET DONNEES DU LABORATOIRE DANS L'HYPERTHERMIE MALIGNE CHEZ L'ENFANT EN PARTICULIER ISOENZYMES DE LA CREATINE KINASEBLUME H; SCHMIDT EW; CAYUELA S et al.1978; ANAESTHESIST; DTSCH.; DA. 1978; VOL. 27; NO 3; PP. 108-114; ABS. ANGL.; BIBL. 13 REF.Article

Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growthCZUBAYKO, F; RIEGEL, A. T; WELLSTEIN, A et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 33, pp 21358-21363, issn 0021-9258Article

Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranololJOUBERT, P. H; VENTER, C. P; WELLSTEIN, A et al.European journal of clinical pharmacology. 1988, Vol 34, Num 4, pp 363-368, issn 0031-6970Article

Agonist binding at alpha2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cationsSCHLOOS, J; WELLSTEIN, A; PALM, D et al.Naunyn-Schmiedeberg's archives of pharmacology. 1987, Vol 336, Num 1, pp 48-59, issn 0028-1298Article

Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plotsWELLSTEIN, A; BELZ, G. G; PALM, D et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 246, Num 1, pp 328-337, issn 0022-3565Article

A method for estimating the potency of angiotensin-converting enzyme inhibitors in manWELLSTEIN, A; ESSIG, J; BELZ, G. G et al.British journal of clinical pharmacology. 1987, Vol 24, Num 3, pp 397-399, issn 0306-5251Article

  • Page / 3